1. Duke BOL. Human onchocerciasis—an overview of the Disease. Acta Leiden. 1990;59:9–24.
2. World Health Organization. Onchocerciasis. Key facts. 2022. Available from: https://www.who.int/news-room/fact-sheets/detail/onchocerciasis. [Accessed 12 September 2023].
3. Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019, Lancet. 2020;396 (10258):1204–22. Onchocerciasis—Level 3 cause. Available from: https://www.thelancet.com/pb-assets/Lancet/gbd/summaries/diseases/onchocerciasis.pdf. [Accessed 12 September 2023].
4. Ghana Health Service. Ghana NTD Master Plan 2016–2020. Expanded Special Project for Elimination of Neglected Tropical Diseases. 2020. Available from: https://espen.afro.who.int/system/files/content/resources/GHANA_NTD_Master_Plan_2016_2020.pdf. [Accessed 12 September 2023].
5. Otabil KB, Ankrah B, Bart-Plange EJ, Donkoh ES, Avarikame FA, Ofori-Appiah FO, et al. Prevalence of epilepsy in the onchocerciasis endemic middle belt of Ghana after 27 years of mass drug administration with ivermectin. Infect Dis Poverty. 2023;12(1):75.